以岭药业：盐酸美金刚原料药上市申请获批

Core Viewpoint - Yiling Pharmaceutical's subsidiary, Wanyang Hengshui Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing application of the chemical raw material, Memantine Hydrochloride, which is used to treat moderate to severe Alzheimer's disease [1] Group 1 - The approved product, Memantine Hydrochloride, is a voltage-dependent, moderately affinity non-competitive NMDA receptor antagonist [1]